Micro-teams for better continuity in Tower Hamlets: we have a problem but we're working on a promising solution!
…, P Cockman, J Hall, E Ovink, S Macklin… - The British Journal of …, 2015 - ncbi.nlm.nih.gov
Micro-teams for better continuity in Tower Hamlets: we have a problem but we’re working on a
promising solution! - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
promising solution! - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study
Background: Converging lines of evidence have implicated the amygdala in the
pathophysiology of posttraumatic stress disorder (PTSD). We previously developed a method for …
pathophysiology of posttraumatic stress disorder (PTSD). We previously developed a method for …
Adaptive platform trials to transform amyotrophic lateral sclerosis therapy development
…, JD Berry, M Quintana, E Macklin… - Annals of …, 2022 - Wiley Online Library
Current therapeutic development in amyotrophic lateral sclerosis (ALS) relies on individual
randomized clinical trials to test a specific investigational product in a single patient …
randomized clinical trials to test a specific investigational product in a single patient …
Long‐term survival of participants in the CENTAUR trial of sodium phenylbutyrate‐taurursodiol in amyotrophic lateral sclerosis
…, SP Dickson, N Knowlton, EA Macklin… - Muscle & …, 2021 - Wiley Online Library
An orally administered, fixed‐dose coformulation of sodium phenylbutyrate‐taurursodiol (PB‐TURSO)
significantly slowed functional decline in a randomized, placebo‐controlled, …
significantly slowed functional decline in a randomized, placebo‐controlled, …
Kenney confuses on permanent residence loss
S Rehaag, A Macklin, L Waldman - Embassy, 2012 - digitalcommons.osgoode.yorku.ca
The clearest example concerns the provision of Bill C-31, Protecting Canada's Immigration
System Act, that will let the minister apply to end a person's refugee and permanent …
System Act, that will let the minister apply to end a person's refugee and permanent …
Apilimod dimesylate in C9orf72 amyotrophic lateral sclerosis: a randomized phase 2a clinical trial
…, A Swenson, PJ Sampognaro, P Pant, EA Macklin… - Brain, 2024 - academic.oup.com
Apilimod dimesylate is a first-in-class phosphoinositide kinase, FYVE-type zinc finger containing
(PIKfyve) inhibitor with favourable clinical safety profile and has demonstrated activity in …
(PIKfyve) inhibitor with favourable clinical safety profile and has demonstrated activity in …
[PDF][PDF] Agent-based computational modeling of glioblastoma predicts that stromal density is central to oncolytic virus efficacy
Oncolytic viruses (OVs) are emerging cancer immunotherapy. Despite notable successes in
the treatment of some tumors, OV therapy for central nervous system cancers has failed to …
the treatment of some tumors, OV therapy for central nervous system cancers has failed to …
[BOOK][B] How Do I Stand
…, DL BRANHAM, A LEGGE, N LISI, V MACKLIN… - 2007 - mysouthsidestand.com
… > Local columnist Sean Kirst with Syracuse Media Group spoke about the importance of
stories reflective of one’s community. “Every child is a story; every story is a treasure,” he said. …
stories reflective of one’s community. “Every child is a story; every story is a treasure,” he said. …
[HTML][HTML] The i-ACT™ in Obesity educational intervention: a pilot study on improving Canadian family physician care in obesity medicine
S Wharton, D Macklin, MP Morin, J Blavignac… - BMC Primary …, 2022 - Springer
Background Obesity is a chronic problem in Canada and although the Canadian Medical
Association recognizes obesity as a disease, health care professionals (HCPs) are not …
Association recognizes obesity as a disease, health care professionals (HCPs) are not …
[HTML][HTML] Obesity in adults: a clinical practice guideline
…, J Kuk, MF Langlois, S Lear, A McInnes, D Macklin… - Cmaj, 2020 - Can Med Assoc
… : Sean Wharton reports receiving honoraria and travel expenses and has participated in
academic advisory boards for Novo Nordisk, Bausch Health, Eli Lilly and Janssen. Sean …
academic advisory boards for Novo Nordisk, Bausch Health, Eli Lilly and Janssen. Sean …